GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » OCI (XKRX:456040) » Definitions » Stock Based Compensation

OCI (XKRX:456040) Stock Based Compensation : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OCI Stock Based Compensation?

OCI's Stock Based Compensation for the three months ended in Mar. 2024 was ₩0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.


OCI Stock Based Compensation Historical Data

The historical data trend for OCI's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OCI Stock Based Compensation Chart

OCI Annual Data
Trend Dec23
Stock Based Compensation
-

OCI Quarterly Data
Jun23 Sep23 Dec23 Mar24
Stock Based Compensation - - - -

OCI Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.


OCI Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of OCI's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


OCI (XKRX:456040) Business Description

Industry
Traded in Other Exchanges
N/A
Address
94, Sogong-ro, Jung-gu, Seoul, KOR, 100-718
OCI is engaged in Solar PV Business, ESS (Energy Storage System), Cogeneration, Urban development projects, and Pharmaceutical-Bio business. The company will operate in Korea, China, and the United States.

OCI (XKRX:456040) Headlines

No Headlines